PLOS
open access
CC BY 4.0
Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Hepatocellular carcinoma surveillance: a health economic evaluation.#148420
- Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC#1094783
- Cost-effectiveness of nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in China: a modeling study with price threshold analysis.#371750
- Results of the National Health Screening Program for Hepatitis C among 56-year-olds, Republic of Korea, 2025.#399847
- Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma#121334
Record · ID 379072
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive